Please enable JavaScript to continue using this application.

Compare $AGIO vs $ZBIO | Chartloom

Compare

$AGIO vs $ZBIO

Agios Pharmaceuticals Inc · Zenas Biopharma Inc

AGIO

Agios Pharmaceuticals Inc

ZBIO

Zenas Biopharma Inc

Compare $AGIO vs $ZBIO

Comparing Agios Pharmaceuticals Inc and Zenas Biopharma Inc

AGIOAgios Pharmaceuticals Inc

ZBIOZenas Biopharma Inc

AGIOAgios Pharmaceuticals Inc

Market cap

$1.89B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.91x

Rev growth (TTM)

140.6%

YTD performance

17.0%

52W performance

-25.3%

FCF yield

-19.3%

ZBIOZenas Biopharma Inc

Market cap

$1.72B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-93.3%

YTD performance

-21.0%

52W performance

5.3%

FCF yield

-16.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AGIO

ZBIO

Detailed metrics comparison

AGIO

Agios Pharmaceuticals Inc

ZBIO

Zenas Biopharma Inc

Market Cap

AGIO$1.89B

ZBIO$1.72B

Enterprise Value

AGIO$1.79B

ZBIO$1.91B

Price

AGIO$31.81

ZBIO$27.26

P/E Ratio

AGION/A

ZBION/A

P/S Ratio

AGIO19.24x

ZBIO1,720.92x

EV/Sales

AGIO18.22x

ZBIO1,913.10x

EV/EBITDA

AGIO2.84x

ZBIO0.00x

P/B Ratio

AGIO1.85x

ZBIO7.47x

P/FCF Ratio

AGION/A

ZBION/A

EV/FCF

AGIO-4.91x

ZBIO-6.57x

PEG Ratio

AGION/A

ZBION/A

Forward P/E (NTM)

AGION/A

ZBION/A

Forward P/S (NTM)

AGIO6.91x

ZBION/A

Revenue (TTM)

AGIO$98M

ZBIO$1M

Revenue Growth (YoY)

AGIO140.6%

ZBIO-93.3%

Forward Rev Growth

AGIO92.6%

ZBIO5296.9%

Gross Margin (TTM)

AGIO92.0%

ZBIO0.0%

Operating Margin (TTM)

AGIO0.0%

ZBIO0.0%

EBITDA Margin (TTM)

AGIO-461.3%

ZBIO-27387.0%

Net Margin (TTM)

AGIO-418.2%

ZBIO-48438.4%

FCF Margin (TTM)

AGIO-371.4%

ZBIO-29097.4%

Net Income (TTM)

AGIO$-411M

ZBIO$-484M

FCF (TTM)

AGIO$-365M

ZBIO$-291M

EPS (TTM)

AGIO-$6.91

ZBIO-$7.67

ROE (TTM)

AGIO-3567.0%

ZBIO-18968.0%

ROA (TTM)

AGIO-3306.0%

ZBIO-8991.0%

ROIC (TTM)

AGIO-3567.0%

ZBIO-10131.0%

Cash

AGIO$100M

ZBIO$197M

Debt

AGIO$0

ZBIO$389M

Net Cash/Debt

AGIO$100M

ZBIO$-192M

Current Ratio (TTM)

AGIO10.22x

ZBIO9.93x

Quick Ratio (TTM)

AGIO9.14x

ZBIO9.77x

Debt/Equity (TTM)

AGIO0.00x

ZBIO1.57x

Debt/Assets (TTM)

AGIO0.0%

ZBIO0.0%

Interest Coverage (TTM)

AGION/A

ZBION/A

Net Debt/EBITDA (TTM)

AGIO0.00x

ZBIO0.00x

Beta

AGIO0.62

ZBIO0.70

52W Performance

AGIO-25.3%

ZBIO5.3%

YTD Performance

AGIO17.0%

ZBIO-21.0%

% from 52W High

AGIO-30.8%

ZBIO-38.9%

% from 52W Low

AGIO43.0%

ZBIO101.9%

Asset Turnover (TTM)

AGIO0.08x

ZBIO0.00x

FCF Yield (TTM)

AGIO-19.3%

ZBIO-16.9%

Earnings Yield (TTM)

AGIO-21.7%

ZBIO-28.1%

Dividend Yield (TTM)

AGION/A

ZBION/A

Rule of 40

AGIO-230.8

ZBIO-29,190.7

EV/GP/RG

AGIO0.06

ZBION/A

Ticker research

View AGIO research View ZBIO research

Metric	AGIO Agios Pharmaceuticals Inc	ZBIO Zenas Biopharma Inc
Market & Valuation
Market Cap	$1.89B	$1.72B
Enterprise Value	$1.79B	$1.91B
Price	$31.81	$27.26
P/E Ratio	N/A	N/A
P/S Ratio	19.24x	1,720.92x
EV/Sales	18.22x	1,913.10x
EV/EBITDA	2.84x	0.00x
P/B Ratio	1.85x	7.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.91x	-6.57x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.91x	N/A
Revenue & Growth
Revenue (TTM)	$98M	$1M
Revenue Growth (YoY)	140.6%	-93.3%
Forward Rev Growth	92.6%	5296.9%
Profitability
Gross Margin (TTM)	92.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-461.3%	-27387.0%
Net Margin (TTM)	-418.2%	-48438.4%
FCF Margin (TTM)	-371.4%	-29097.4%
Net Income (TTM)	$-411M	$-484M
FCF (TTM)	$-365M	$-291M
EPS (TTM)	-$6.91	-$7.67
ROE (TTM)	-3567.0%	-18968.0%
ROA (TTM)	-3306.0%	-8991.0%
ROIC (TTM)	-3567.0%	-10131.0%
Financial Health
Cash	$100M	$197M
Debt	$0	$389M
Net Cash/Debt	$100M	$-192M
Current Ratio (TTM)	10.22x	9.93x
Quick Ratio (TTM)	9.14x	9.77x
Debt/Equity (TTM)	0.00x	1.57x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	0.70
52W Performance	-25.3%	5.3%
YTD Performance	17.0%	-21.0%
% from 52W High	-30.8%	-38.9%
% from 52W Low	43.0%	101.9%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.00x
FCF Yield (TTM)	-19.3%	-16.9%
Earnings Yield (TTM)	-21.7%	-28.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-230.8	-29,190.7
EV/GP/RG	0.06	N/A
Ticker research	View AGIO research	View ZBIO research

Valuation

P/S Ratio

AGIO

19.24x

ZBIO

1,720.92x

EV/FCF

ZBIO

-6.57x

AGIO

-4.91x

Growth & revenue

Revenue Growth TTM

AGIO

140.6%

ZBIO

-93.3%

Forward Revenue Growth

ZBIO

5296.9%

AGIO

92.6%

Profitability & performance

Gross Margin

AGIO

92.0%

ZBIO

0.0%

ROE

AGIO

-3567.0%

ZBIO

-18968.0%

FCF Yield %

ZBIO

-16.9%

AGIO

-19.3%

52-Week Performance

ZBIO

5.3%

AGIO

-25.3%

Detailed metrics comparison

AGIO

Agios Pharmaceuticals Inc

ZBIO

Zenas Biopharma Inc

Market Cap

AGIO$1.89B

ZBIO$1.72B

Enterprise Value

AGIO$1.79B

ZBIO$1.91B

Price

AGIO$31.81

ZBIO$27.26

P/E Ratio

AGION/A

ZBION/A

P/S Ratio

AGIO19.24x

ZBIO1,720.92x

EV/Sales

AGIO18.22x

ZBIO1,913.10x

EV/EBITDA

AGIO2.84x

ZBIO0.00x

P/B Ratio

AGIO1.85x

ZBIO7.47x

P/FCF Ratio

AGION/A

ZBION/A

EV/FCF

AGIO-4.91x

ZBIO-6.57x

PEG Ratio

AGION/A

ZBION/A

Forward P/E (NTM)

AGION/A

ZBION/A

Forward P/S (NTM)

AGIO6.91x

ZBION/A

Revenue (TTM)

AGIO$98M

ZBIO$1M

Revenue Growth (YoY)

AGIO140.6%

ZBIO-93.3%

Forward Rev Growth

AGIO92.6%

ZBIO5296.9%

Gross Margin (TTM)

AGIO92.0%

ZBIO0.0%

Operating Margin (TTM)

AGIO0.0%

ZBIO0.0%

EBITDA Margin (TTM)

AGIO-461.3%

ZBIO-27387.0%

Net Margin (TTM)

AGIO-418.2%

ZBIO-48438.4%

FCF Margin (TTM)

AGIO-371.4%

ZBIO-29097.4%

Net Income (TTM)

AGIO$-411M

ZBIO$-484M

FCF (TTM)

AGIO$-365M

ZBIO$-291M

EPS (TTM)

AGIO-$6.91

ZBIO-$7.67

ROE (TTM)

AGIO-3567.0%

ZBIO-18968.0%

ROA (TTM)

AGIO-3306.0%

ZBIO-8991.0%

ROIC (TTM)

AGIO-3567.0%

ZBIO-10131.0%

Cash

AGIO$100M

ZBIO$197M

Debt

AGIO$0

ZBIO$389M

Net Cash/Debt

AGIO$100M

ZBIO$-192M

Current Ratio (TTM)

AGIO10.22x

ZBIO9.93x

Quick Ratio (TTM)

AGIO9.14x

ZBIO9.77x

Debt/Equity (TTM)

AGIO0.00x

ZBIO1.57x

Debt/Assets (TTM)

AGIO0.0%

ZBIO0.0%

Interest Coverage (TTM)

AGION/A

ZBION/A

Net Debt/EBITDA (TTM)

AGIO0.00x

ZBIO0.00x

Beta

AGIO0.62

ZBIO0.70

52W Performance

AGIO-25.3%

ZBIO5.3%

YTD Performance

AGIO17.0%

ZBIO-21.0%

% from 52W High

AGIO-30.8%

ZBIO-38.9%

% from 52W Low

AGIO43.0%

ZBIO101.9%

Asset Turnover (TTM)

AGIO0.08x

ZBIO0.00x

FCF Yield (TTM)

AGIO-19.3%

ZBIO-16.9%

Earnings Yield (TTM)

AGIO-21.7%

ZBIO-28.1%

Dividend Yield (TTM)

AGION/A

ZBION/A

Rule of 40

AGIO-230.8

ZBIO-29,190.7

EV/GP/RG

AGIO0.06

ZBION/A

Ticker research

View AGIO research View ZBIO research

Metric	AGIO Agios Pharmaceuticals Inc	ZBIO Zenas Biopharma Inc
Market & Valuation
Market Cap	$1.89B	$1.72B
Enterprise Value	$1.79B	$1.91B
Price	$31.81	$27.26
P/E Ratio	N/A	N/A
P/S Ratio	19.24x	1,720.92x
EV/Sales	18.22x	1,913.10x
EV/EBITDA	2.84x	0.00x
P/B Ratio	1.85x	7.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.91x	-6.57x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.91x	N/A
Revenue & Growth
Revenue (TTM)	$98M	$1M
Revenue Growth (YoY)	140.6%	-93.3%
Forward Rev Growth	92.6%	5296.9%
Profitability
Gross Margin (TTM)	92.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-461.3%	-27387.0%
Net Margin (TTM)	-418.2%	-48438.4%
FCF Margin (TTM)	-371.4%	-29097.4%
Net Income (TTM)	$-411M	$-484M
FCF (TTM)	$-365M	$-291M
EPS (TTM)	-$6.91	-$7.67
ROE (TTM)	-3567.0%	-18968.0%
ROA (TTM)	-3306.0%	-8991.0%
ROIC (TTM)	-3567.0%	-10131.0%
Financial Health
Cash	$100M	$197M
Debt	$0	$389M
Net Cash/Debt	$100M	$-192M
Current Ratio (TTM)	10.22x	9.93x
Quick Ratio (TTM)	9.14x	9.77x
Debt/Equity (TTM)	0.00x	1.57x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	0.70
52W Performance	-25.3%	5.3%
YTD Performance	17.0%	-21.0%
% from 52W High	-30.8%	-38.9%
% from 52W Low	43.0%	101.9%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.00x
FCF Yield (TTM)	-19.3%	-16.9%
Earnings Yield (TTM)	-21.7%	-28.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-230.8	-29,190.7
EV/GP/RG	0.06	N/A
Ticker research	View AGIO research	View ZBIO research